David W. Stroman, SVP, Ophthalmic Product Devt at NovaBay Pharmaceuticals, Inc. (NBY), bought 10,000 shares at $1.24 ($12K) on 2012-12-06, disclosed to the SEC on 2012-12-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.